Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04980157 · ClinicalTrials.gov registry record

CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers

A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
39
Enrollment target

NCT04980157: Completed study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT04980157 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04980157 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
39 participants
Enrollment target

Study Summary

The purpose of the study is to examine the efficacy of educational materials to promote hepatitis C virus (HCV) screening and colorectal cancer (CRC) screening uptake among adults born between 1945-1965.

Primary Outcome

Participants will be interviewed regarding their HCV knowledge on Day 1 prior to receiving educational materials. They will be interviewed once again approximately one week after receiving educational materials.

Interventions

  • BEHAVIORAL CARES-HCV

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2021-11-01
Est. Completion 2022-12-01

What the finished NCT04980157 record still lists

NCT04980157 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which CARES-HCV is the first listed.

NCT04980157 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04980157 about?

NCT04980157 is a clinical study titled "CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers". The purpose of the study is to examine the efficacy of educational materials to promote hepatitis C virus (HCV) screening and colorectal cancer (CRC) screening uptake among adults born between 1945-1965.

What is the current status of trial NCT04980157?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2021-11-01. Estimated completion is 2022-12-01.

What interventions are being tested in trial NCT04980157?

The interventions under investigation include: CARES-HCV (BEHAVIORAL).

Who is sponsoring clinical trial NCT04980157?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04980157, the US trial registry maintained by the National Library of Medicine. NCT04980157 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.